YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(8)
- Austria(1)
- Belgium(3)
- Canada(59)
- China(20)
- Denmark(2)
- Estonia(1)
- Finland(1)
- France(13)
- Germany(39)
- Greece(2)
- Hong Kong(1)
- Hungary(2)
- India(75)
- Ireland(2)
- Israel(3)
- Italia (5)
- Japan(2)
- Latvia(1)
- Mexico(2)
- New Zealand(1)
- Peru(1)
- Poland(2)
- Portugal(3)
- Romania(1)
- Singapore(1)
- Slovenia(2)
- South Korea(6)
- Spain(14)
- Sweden(3)
- Switzerland(23)
- Taiwan(3)
- The Czech Republic(1)
- The Netherlands(5)
- Turkey(3)
- Ukraine(1)
- United Kingdom(44)
- United States(647)
- Vietnam(1)
Contract Service Directory
MilliporeSigma
Company Headquarters
250 Frankfurter Straße,
Darmstadt, HE 64293
Germany
Company Description
MilliporeSigma provides comprehensive services whether you are developing and commercializing complex small molecule APIs or biologic drug substances such as ADCs to viral vectors. We combine a broad portfolio of products, technical expertise and single point of contact project management to deliver industry-leading analytical and process development support across all stages of drug development and manufacture.
Contract Service Directory
- Biodiagnostic Manufacturing & Devices
- Biologics Manufacturing
- Cell Line Construction & Development
- Drug Development Services
- Mammalian Cell Culture
- Manufacturing, Antibody-Drug Conjugates
- Manufacturing, API
- Manufacturing, API, High Potency
- Manufacturing, Biologics
- Manufacturing, Cytotoxic & High Potency Compounds
- Process Development/Scale-Up Services
Content From MilliporeSigma
-
Future-Proof Your Process with Modular Flexibility Today
MilliporeSigma unveils its new Mobius® iFlex Bioreactor family for fed-batch and perfusion upstream processes.Sponsored Content Released on 09.07.2023
-
Bridging the Sponsor – CMO Data Gulf
How do sponsors and CMOs realize the advantages of their partnership while avoiding the pitfalls of clunky data sharing?Sponsored Content Released on 06.06.2023
-
Improve Process Economics & Enable High Protein Concentrations
This whitepaper spotlights how excipient combinations can enhance manufacturability and final concentration of mAb formulations.White Papers / Tech Papers Released on 04.03.2023
-
Glucose Control in Cell Culture Using Raman
This automated approach minimizes the number of human interventions needed and reduces the risk of contamination and batch failures.Sponsored Content Released on 03.21.2023
-
Enhancing Ease of Use, Batch Turnaround, and Process Flexibility
The Pellicon® Capsule is the first of its kind—a true single-use TFF device that streamlines bioprocessing with its innovative, simplified design.Sponsored Content Released on 12.08.2022
-
Enhancement of Tablet Coating Using an Innovative Functional Excipient
This white paper describes key considerations and provides guidance on the preparation of a coating formulation.White Papers / Tech Papers Released on 08.30.2022
-
Explore the Next Generation Manufacturing of the Most Potent Compounds in Pharma
MilliporeSigma's new HPAPI contract manufacturing facility brings unmatched capacity to the market.Sponsored Content Released on 06.09.2022
-
Overcoming Challenges in Ophthalmic Formulations Through Polymer Selection
This white paper provides an overview of polymers that can be used in ophthalmic formulations and highlights advantages offered using polyvinyl alcohol (PVA).White Papers / Tech Papers Released on 06.02.2022
-
Regulatory Considerations for Excipients Used in Lipid Nanoparticles
This whitepaper provides an overview on the regulatory classification and emerging regulatory challenges for LNP, liposomes, and novel excipients.White Papers / Tech Papers Released on 06.01.2022
-
Challenges and Solutions in Viral Vector Manufacturing
The accelerated pathway through the clinic of viral vector-based cell and gene therapies puts pressure on developers to find a skilled partner.Sponsored Content Released on 03.03.2022
-
The Viscosity Reduction Platform: Viscosity-reducing excipients for protein formulation
This white paper evaluates the viscosity-reducing capacities of excipients and excipient combinations.White Papers / Tech Papers Released on 01.20.2022
-
Modification of Virus Spiking Procedures for Continuous Processes
This white paper demonstrates the feasibility of novel virus spiking strategies to meet the needs of continuous processes.Sponsored Content Released on 12.10.2021
